Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer

BACKGROUND: To clarify the significant clinicopathological and postdosimetric parameters to predict PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer. METHODS: We studied 200 consecutive patients who received LDR-brachytherapy between July 2004...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tanaka, Nobumichi, Asakawa, Isao, Fujimoto, Kiyohide, Anai, Satoshi, Hirayama, Akihide, Hasegawa, Masatoshi, Konishi, Noboru, Hirao, Yoshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487947/
https://ncbi.nlm.nih.gov/pubmed/22974428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-12-28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados